Diagnostic Cardiovascular Imaging and Therapeutic Strategies in Pregnancy: JACC Focus Seminar 4/5

J Am Coll Cardiol. 2021 Apr 13;77(14):1813-1822. doi: 10.1016/j.jacc.2021.01.056.

Abstract

The prevalence of cardiovascular disease (CVD) in pregnancy, both diagnosed and previously unknown, is rising, and CVD is a leading cause of maternal morbidity and mortality. Historically, women of child-bearing potential have been underrepresented in research, leading to lasting knowledge gaps in the cardiovascular care of pregnant and lactating women. Despite these limitations, clinicians should be familiar with the safety of frequently used diagnostic and therapeutic interventions to adequately care for this at-risk population. This review, the fourth of a 5-part series, provides evidence-based recommendations regarding the use of common cardiovascular diagnostic tests and medications in pregnant and lactating women.

Keywords: cardio-obstetrics; imaging; lactation; medication; pregnancy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cardiovascular Agents / pharmacology*
  • Cardiovascular Diseases* / classification
  • Cardiovascular Diseases* / diagnosis
  • Cardiovascular Diseases* / drug therapy
  • Diagnostic Techniques, Cardiovascular* / adverse effects
  • Female
  • Humans
  • Lactation / drug effects
  • Pregnancy
  • Pregnancy Complications, Cardiovascular* / classification
  • Pregnancy Complications, Cardiovascular* / diagnosis
  • Pregnancy Complications, Cardiovascular* / drug therapy
  • Pregnancy, High-Risk
  • Risk Adjustment / methods

Substances

  • Cardiovascular Agents